Notably, as shown in Figure 6, miR-16, miR-143 and miR-203 were highly expressed in ER positive breast tumor, in contrast, miR-631 was not differentially expressed between ER positive and negative breast cancer, suggesting these anti-onco miRNAs may play an important role in breast cancer progression and response to chemotherapy. This evidence concerns the gene ESR1 and breast neoplasm.